Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Nasdaq: CRBP · CIK 0001595097 · United States
Every official Corbus Pharmaceuticals Holdings, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CRBP filings
Corbus Pharmaceuticals Holdings, Inc. documents
- Corbus Pharmaceuticals Holdings, Inc. 10-K 2026CRBP 10-K 2026: annual report for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. 10-K 2025CRBP 10-K 2025: annual report for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. 10-K 2024CRBP 10-K 2024: annual report for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. 10-K 2023CRBP 10-K 2023: annual report for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. 10-K 2022CRBP 10-K 2022: annual report for fiscal 2022
- Corbus Pharmaceuticals Holdings, Inc. 10-Q 2026CRBP 10-Q 2026: quarterly report for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. 10-Q 2025CRBP 10-Q 2025: quarterly report for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. 10-Q 2024CRBP 10-Q 2024: quarterly report for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. 10-Q 2023CRBP 10-Q 2023: quarterly report for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. 10-Q 2022CRBP 10-Q 2022: quarterly report for fiscal 2022
- Corbus Pharmaceuticals Holdings, Inc. 8-K 2026CRBP 8-K 2026: current report for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. 8-K 2025CRBP 8-K 2025: current report for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. 8-K 2024CRBP 8-K 2024: current report for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. 8-K 2023CRBP 8-K 2023: current report for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. 8-K 2022CRBP 8-K 2022: current report for fiscal 2022
- Corbus Pharmaceuticals Holdings, Inc. DEF 14A 2026CRBP DEF 14A 2026: proxy statement for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. DEF 14A 2025CRBP DEF 14A 2025: proxy statement for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. DEF 14A 2024CRBP DEF 14A 2024: proxy statement for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. DEF 14A 2023CRBP DEF 14A 2023: proxy statement for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. DEF 14A 2022CRBP DEF 14A 2022: proxy statement for fiscal 2022
- Corbus Pharmaceuticals Holdings, Inc. Form 4 2026CRBP Form 4 2026: insider trading filing for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. Form 4 2025CRBP Form 4 2025: insider trading filing for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. Form 4 2024CRBP Form 4 2024: insider trading filing for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. Form 4 2023CRBP Form 4 2023: insider trading filing for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. Form 4 2022CRBP Form 4 2022: insider trading filing for fiscal 2022
- Corbus Pharmaceuticals Holdings, Inc. S-1 2026CRBP S-1 2026: registration statement for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. S-1 2025CRBP S-1 2025: registration statement for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. S-1 2024CRBP S-1 2024: registration statement for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. S-1 2023CRBP S-1 2023: registration statement for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. S-1 2022CRBP S-1 2022: registration statement for fiscal 2022
- Corbus Pharmaceuticals Holdings, Inc. 13F 2026CRBP 13F 2026: institutional holdings for fiscal 2026
- Corbus Pharmaceuticals Holdings, Inc. 13F 2025CRBP 13F 2025: institutional holdings for fiscal 2025
- Corbus Pharmaceuticals Holdings, Inc. 13F 2024CRBP 13F 2024: institutional holdings for fiscal 2024
- Corbus Pharmaceuticals Holdings, Inc. 13F 2023CRBP 13F 2023: institutional holdings for fiscal 2023
- Corbus Pharmaceuticals Holdings, Inc. 13F 2022CRBP 13F 2022: institutional holdings for fiscal 2022
More companies